Genmab — Februar 2020
-
Beklager at vi har haft udfald til morgen.
-
" I den forbindelse kommer amerikanske FDA i marts med en afgørelse om et middel, Genmab har udviklet i samarbejde med Novartis." That seems a bit too soon, doesn't it? I expect closer to june? https://www.berlingske.dk/aktier/finanskalender-din-guide-til-de-vigtigste-begivenheder-i-uge-8-0
-
New small trial : Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab https://clinicaltrials.gov/ct2/show/NCT04270175
-
Det satser jeg på. Kommunikationsmanden Nicolai er på barsel. Andrew har taget over, men er voldsomt ophængt. Vi har således ikke fået en dato endnu. Jeg har prøvet
siden starten af januar at få det på plads. -
Har denne været nævnt her? GSK, phase 3: Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma (DREAMM 7). https://clinicaltrials.gov/ct2/show/NCT04246047?term=daratumumab+gsk&draw=2&rank=1
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind